Weight Loss

Peptides studied for metabolic regulation, appetite modulation, and body weight management research. These compounds include GLP-1 receptor agonists and other metabolic modulators.

Weight Loss Products

11 products available

AOD9604

AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the side effects of full growth hormone. Unlike full GH, it does not increase IGF-1, affect glucose metabolism, or cause insulin resistance.

COA Verified

Purity: ≥98% (HPLC verified)

Cagrilintide 5mg + Semaglutide 5mg Blend

Research blend of Cagrilintide and Semaglutide. RaysunPeptide manufactures and supplies Cagrilintide 5mg + Semaglutide 5mg Blend for qualified research, laboratory, and B2B applications.

COA Verified

Purity: ≥98% (HPLC verified)

Cagrilintide

Novel long-acting lipidated amylin analog functioning as dual amylin and calcitonin receptor agonist for weight management and type 2 diabetes. Phase 3 trials demonstrate 22.7% weight loss with CagriSema combination.

COA Verified

Purity: ≥98% (HPLC verified)

HGH Fragment 176-191

HGH Fragment 176-191 is the fat-burning segment of human growth hormone, corresponding to amino acids 176 through 191 of the full GH molecule. It stimulates lipolysis and inhibits lipogenesis without the growth-promoting or insulin-disrupting effects associated with full-length HGH. AOD-9604 is a modified version of this fragment with an added N-terminal tyrosine residue.

COA Verified

Purity: ≥98% (HPLC verified)

Liraglutide

A long-acting GLP-1 receptor agonist structurally related to human GLP-1 and used clinically for type 2 diabetes and chronic weight management.

COA Verified

Purity: ≥98% (HPLC verified)

Mazdutide

First-in-class dual GLP-1 and glucagon receptor agonist combining appetite suppression with thermogenesis stimulation. Phase 3 trials demonstrated superiority over semaglutide for weight loss and glycemic control.

COA Verified

Purity: ≥98% (HPLC verified)

Retatrutide 5mg + Cagrilintide 5mg Blend

Research blend of Retatrutide and Cagrilintide. RaysunPeptide manufactures and supplies Retatrutide 5mg + Cagrilintide 5mg Blend for qualified research, laboratory, and B2B applications.

COA Verified

Purity: ≥98% (HPLC verified)

Retatrutide

Novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors. Phase II trials demonstrated 24.2% weight loss at 48 weeks—the highest recorded for obesity medications.

COA Verified

Purity: ≥98% (HPLC verified)

Semaglutide

Long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Over 17,000 trial participants have demonstrated significant efficacy through appetite suppression and glycemic control. The 7-day half-life enables convenient weekly dosing.

COA Verified

Purity: ≥98% (HPLC verified)

Survodutide

Investigational dual receptor agonist targeting metabolic disease through balanced GLP-1R and GCGR activation. Phase 2/3 clinical trials demonstrate superior weight loss and MASH treatment efficacy.

COA Verified

Purity: ≥98% (HPLC verified)

Tirzepatide

Revolutionary dual receptor agonist FDA-approved for type 2 diabetes and chronic weight management. Demonstrates efficacy superior to single-mechanism alternatives with 15-22% body weight reduction in clinical trials.

COA Verified

Purity: ≥98% (HPLC verified)

About Weight Loss

Weight loss peptides include GLP-1 receptor agonists (Semaglutide, Tirzepatide, Liraglutide), triple agonists (Retatrutide), and amylin analogs (Cagrilintide). These compounds are used in metabolic research. RaySunPeptide supplies these peptides for qualified research and laboratory applications only.